Endocrine Technology Overview
- Founded
- 2002
- Status
- Private
- Latest Deal Type
- Early Stage VC
- (Cancelled)
- Latest Deal Amount
- $20M
Endocrine Technology General Information
Description
Owner and operator of a biotechnology company. The company focuses on filing New patent applications for the therapy of diabetes and its complications.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 326 Livingston Street
- New York, NY 11217
- United States
+1 (718) 000-0000
Endocrine Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | $20M | Cancelled | Startup | |||
| 2. Grant | 00.00 | 00.00 | Completed | Startup | ||
| 1. Angel (individual) | $2.2M | $2.2M | Completed | Startup |
Endocrine Technology Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kumarpal Shah MD | Founder, Owner & President, Business Development |